Quantification of oxidative phosphorylation enzymes after blue native electrophoresis and two‐dimensional resolution: Normal complex I protein amounts in Parkinson's disease conflict with reduced catalytic activities
- 1 January 1995
- journal article
- research article
- Published by Wiley in Electrophoresis
- Vol. 16 (1) , 763-770
- https://doi.org/10.1002/elps.11501601125
Abstract
Blue native polyacrylamide gel electrophoresis (BN-PAGE), a method for the isolation of native membrane proteins from biological membranes, was adapted to the isolation of oxidative phosphorylation (OXPHOS) enzymes from milligram amounts of human tissues. Combined with Tricine-sodium dodecyl sulfate (SDS)-PAGE in the second dimension, the protein subunits of OXPHOS complexes could be analyzed and quantified. The characteristics of the technique are described and protocols for processing different tissues are provided. The technique was applied for the analysis of defects of OXPHOS complexes in Parkinson's disease. A significant reduction of complex V was observed in one case. Absolutely normal complex I protein amounts were in contrast to reduced catalytic activities of complex I in Parkinson's disease. This discrepancy can be explained by binding of endogenous complex I inhibitors or by alterations of a protein subunit not affecting the assemblage of the complex but modifying the enzymatic properties.Keywords
This publication has 24 references indexed in Scilit:
- Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridinePublished by Elsevier ,2002
- Human Diseases with Defects in Oxidative Phosphorylation. 1. Decreased Amounts of Assembled Oxidative Phosphorylation Complexes in Mitochondrial EncephalomyopathiesEuropean Journal of Biochemistry, 1995
- Human Diseases with Defects in Oxidative PhosphorylationEuropean Journal of Biochemistry, 1995
- Human Diseases with Defects in Oxidative PhosphorylationEuropean Journal of Biochemistry, 1995
- BRAIN, SKELETAL MUSCLE AND PLATELET HOMOGENATE MITOCHONDRIAL FUNCTION IN PARKINSON'S DISEASEBrain, 1992
- Identification of the subunits of F1F0-ATPase from bovine heart mitochondriaBiochemistry, 1991
- Anatomic and Disease Specificity of NADH CoQ1 Reductase (Complex I) Deficiency in Parkinson's DiseaseJournal of Neurochemistry, 1990
- Mitochondrial Complex I Deficiency in Parkinson's DiseaseJournal of Neurochemistry, 1990
- Purification of cytochrome‐c oxidase retaining its pulsed formEuropean Journal of Biochemistry, 1989
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983